Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04677114 · ClinicalTrials.gov registry record · Phase 2
Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections
A Phase 2 study of Opioid Use Disorder and Drug Use, sponsored by Laura Fanucchi.
- Completed
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT04677114 is a Phase 2 study of Opioid Use Disorder and Drug Use that has completed, run by Laura Fanucchi. The registered enrollment target is 71 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04677114, a Phase 2 study of Opioid Use Disorder and Drug Use, has completed, sponsored by Laura Fanucchi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the efficacy of an integrated outpatient treatment model for persons with opioid use disorder and injection related infections. The investigators hypothesize that outpatient antibiotic treatment coupled with comprehensive treatment for opioid use disorder will demonstrate a safe and effective way to manage patients. Results could improve the current protocols for the treatment of individuals with opioid use disorder and severe infections.
Conditions Studied
Interventions
- DRUG Buprenorphine and Outpatient Parenteral Antibiotic Therapy
- DRUG Buprenorphine and standard of care antibiotic treatment
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2021-03-16 |
| Est. Completion | 2025-03-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04677114
The ClinicalTrials.gov registry entry for NCT04677114 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The listed sponsor is Laura Fanucchi, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Buprenorphine and Outpatient Parenteral Antibiotic Therapy is the first listed.
NCT04677114 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04677114 about?
NCT04677114 is a clinical study titled "Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections". This study will assess the efficacy of an integrated outpatient treatment model for persons with opioid use disorder and injection related infections. The investigators hypothesize that outpatient antibiotic treatment coupled with comprehensive treatment for opioid use disorder will demonstrate a sa...
What is the current status of trial NCT04677114?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2021-03-16. Estimated completion is 2025-03-06.
What conditions does trial NCT04677114 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Drug Use.
What interventions are being tested in trial NCT04677114?
The interventions under investigation include: Buprenorphine and Outpatient Parenteral Antibiotic Therapy (DRUG), Buprenorphine and standard of care antibiotic treatment (DRUG).
Who is sponsoring clinical trial NCT04677114?
This trial is sponsored by Laura Fanucchi, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04677114 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Remotely Observed Methadone Evaluation II
RECRUITING · Phase 2
-
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
RECRUITING · Phase 2
-
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
RECRUITING · Phase 2
-
Ketamine for Opioid Use Disorder
RECRUITING · Phase 2
-
Brief Digitally-Enhanced Intervention for Reducing Alcohol Use During MOUD
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.